Ads
related to: is belimumab approved for lupus patients to take medication for pain- Dosing & Admin Info
Learn About Dosing & Administration
And Find Helpful Resources & Info.
- FAQS
Read Frequently Asked Questions
About BENLYSTA And Stay Informed.
- Read FAQs About BENLYSTA
Find Answers To Questions Including
Facts & Financial Aid Information.
- Important Safety Info
Learn About Possible Side Effects
And Risks When Taking BENLYSTA.
- Risks And Side Effects
Read The Potential Risks & Common
Side Effects That May Occur.
- Find Patient Information
Learn More About BENLYSTA
On The Official Patient Website.
- Dosing & Admin Info
Search results
Results From The WOW.Com Content Network
Belimumab is primarily used in people with systemic lupus erythematosus. When it was introduced in 2011, it was the first new drug approved to treat lupus in 56 years. [8] Sales rose to $31.2 million in the first quarter of 2012. [37] The total cost for the first year of treatment with belimumab is $28,000. [38]
It is given intravenously to cSLE patients with active disease but should not be given to cSLE patients who have active neuropsychiatric cSLE, acute, severe systemic lupus erythematosus disease, or are taking prednisone at doses greater that 1.5 mg per kg per day. Patients taking belimumab have an increased susceptibility to infections. [65]
Hydroxychloroquine was approved by the FDA for lupus in 1955. [120] Some drugs approved for other diseases are used for SLE 'off-label'. In November 2010, an FDA advisory panel recommended approving belimumab (Benlysta) as a treatment for the pain and flare-ups common in lupus. The drug was approved by the FDA in March 2011. [121] [122]
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Voclosporin, sold under the brand name Lupkynis, is a calcineurin inhibitor used as an immunosuppressant medication for the treatment of lupus nephritis. [2] [4] It is an analog of ciclosporin that has enhanced action against calcineurin and greater metabolic stability.
Treatment consists primarily of immunosuppressive drugs (e.g., hydroxychloroquine and corticosteroids). A second-line drug is methotrexate in its low-dose schedule. [18] [19] In 2011, the U.S. Food and Drug Administration (FDA) approved the first new drug for lupus in more than 50 years to be used in the US, belimumab. [20]
Ads
related to: is belimumab approved for lupus patients to take medication for pain